SCHEMBL30353077

SCHEMBL30353077

CN(CC1CC1)c1cc(Oc2cccc(C#N)c2)n(C)n1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 1/20 0.40
TBXAS1 P24557 1/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
FGFR3 P22607 1/20 0.35
BACE1 P56817 2/20 0.35
MGLL Q99685 2/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
PGGT1B P53609 1/20 0.35
GRIA2 P42262 1/20 0.34
ICMT O60725 1/20 0.34
FFAR1 O14842 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353122 0.82 TBXAS1 (0.38) TBXAS1MGLLFNTAFNTBPGGT1B
SCHEMBL30353093 0.76 TBXAS1 (0.38) TBXAS1MGLLFNTAFNTBPGGT1B
SCHEMBL30353071 0.76 TBXAS1 (0.36) TBXAS1MGLLFNTAFNTBPGGT1B
SCHEMBL25058086 0.68 EGLN2 (0.31) EGLN2
SCHEMBL1848360 0.65 SLC6A2 (0.57) TBXAS1SLC6A2SLC6A4SLC6A3
SCHEMBL8379001 0.64 PDE4A (0.54) TBXAS1SLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL3605627 0.63 MET (0.52) DRD2DRD3MGLLSLC6A2SLC6A4
SCHEMBL3601894 0.62 DRD2 (0.50) TBXAS1DRD2DRD3MGLLSLC6A2
SCHEMBL509344 0.62 KCNH2 (0.41) TBXAS1FNTAFNTBPGGT1BGRIA2
SCHEMBL27839327 0.62 PDE4A (0.53) TBXAS1SLC6A2SLC6A4SLC6A3GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996910-A Aryl or heteroaryl derivatives 帝人制药株式会社 2023-04-21 CN claimed
CN-115996910-A Aryl or heteroaryl derivatives 帝人制药株式会社 2023-04-21 CN disclosed